Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 8, 2001, Pages 2229-2237

  Bestman Smith, J ^a   Piret, J ^a   Desormeaux A ^a   Tremblay, M J ^a   Omar, R F ^a   Bergeron, M G ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DODECYL SULFATE SODIUM; LUCIFERASE; SURFACTANT; THROMBOSPONDIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL FUSION; CONCENTRATION RESPONSE; ENDOCYTOSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEXUALLY TRANSMITTED DISEASE; VESICULAR STOMATITIS VIRUS; VIRUS ADSORPTION; VIRUS INACTIVATION; VIRUS INFECTIVITY;

CELL MEMBRANE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, VIRAL; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; LUCIFERASES; SEXUALLY TRANSMITTED DISEASES; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS REPLICATION;

EID: 0034927825     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.8.2229-2237.2001     Document Type: Article

References (62)

1. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus
2. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects
3. Future contraceptives
4. Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay
5. Comparative in vitro study of contraceptive agents with anti-HIV activity: Gramicidin, nonoxynol-9 and gossypol
6. Chemokine receptors and HIV
7. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphocyte-dependent cell lines
8. Trends in sexual risk behaviors among high school students - United States, 1991-1997
9. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by super-infection of nonproductively infected cell lines with recombinant luciferase-encoding viruses
10. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells
11. HIV 'cofactor' comes in for more heavy fire
12. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
13. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
14. Why do homosexual men relapse into unsafe sex? Predictors of resumption of unprotected anogenital intercourse with casual partners
15. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry
16. Inter-relationship between gender relations and the HIV/AIDS epidemic: Some possible considerations for policies and programmes
17. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania
18. HIV interactions with CD4: A continuum of conformations and consequences
19. Challenges for the development of female-controlled vaginal microbicides
20. The effectiveness of barrier methods of contraception in preventing the spread of HIV
21. The protective effect of nonoxynol-9 against HIV infection
22. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
23. How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus
24. The spermicide nonoxynol-9 does not inactivate papillomavirus
25. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses
26. Observations from the CDC. The urgent need for new HIV/STD prevention options for women
27. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in vitro
28. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
29. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate
30. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes
31. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
32. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein
33. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen
34. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
35. Cytosolic gag p24 as an index of productive entry of human immunodeficiency virus type 1
36. Maintenance of behavioral change in a cohort of homosexually active men
37. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule
38. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent
39. Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin
40. Co-receptors for HIV-1 entry
41. Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface
42. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity
43. An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation
44. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses
45. The epidemiology of the acquired immunodeficiency syndrome in the 1990s
46. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: An approach to postexposure prophylaxis
47. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases
48. Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases
49. Contraceptives of the future in the light of HIV infection
50. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity
51. Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects
52. HIV prevention: The need for methods women can use
53. The first total synthesis of natural (+)-terpestacin, syncytium formation inhibitor
54. The acquisition of host-encoded proteins by nascent HIV-1
55. Advances in topical microbicides
56. The need for vaginal microbicides with antiviral specificity
57. pH modification of the effects of detergents on the stability of enteric viruses
58. The use of nonoxynol-9 for protection against cervical gonorrhea
59. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium
60. Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution
61. Generation of high-titer pseudotyped retroviral vectors with very broad host range
62. Barrier contraceptive use and HIV infection among high-risk women in Cameroon